早期肺癌肺叶切除术的手术时长是否增加围手术期并发症?
本研究利用胸外科医师学会普胸外科数据库,纳入17852例早期非小细胞肺癌肺叶切除术患者,将手术时长作为连续变量分析。结果显示,开胸和微创肺叶切除术的手术时长与术中红细胞输注及住院时间>5天风险增加相关;开胸手术时长还与肺炎、肺不张及非计划ICU入住风险增加相关。手术时长与再入院或30天死亡率无关。
要点
- 开胸、胸腔镜和机器人肺叶切除术的平均时长分别为178±84、185±73和214±82分钟(P<.001)。
- 开胸和微创肺叶切除术的手术时长均与术中红细胞输注和住院时间>5天风险增加相关(P<.001)。
- 开胸肺叶切除术的手术时长与肺炎、肺不张(P<.001)及非计划ICU入住(P=.006)风险增加相关。
核心结论
- 早期肺癌肺叶切除术手术时长较长与术后并发症和住院时间增加相关。
- 手术时长对长期生存的影响尚不清楚,但未检测到短期死亡率差异。
- 外科医生和医院系统应采取不牺牲安全性和肿瘤学结局的措施来缩短手术时长。
研究设计与样本
- 回顾性数据库分析,查询胸外科医师学会普胸外科数据库。
- 纳入17852例早期非小细胞肺癌肺叶切除术患者,手术时长作为连续变量。
- 进行单因素和多因素分析,比较患者和临床特征与围手术期结局及手术时长。
- 机器人病例与胸腔镜病例在时长分析中合并为微创组。
- 所有分析在SAS v9.4中进行,显著性水平为.05。
主要发现
- 开胸、胸腔镜和机器人肺叶切除术的平均时长分别为178±84、185±73和214±82分钟(P<.001)。
- 最常见并发症为 prolonged air leak(12.3%)、心房颤动(12%)、肺炎(4.4%)和需支气管镜治疗的肺不张(4.1%)。
- 开胸和微创肺叶切除术的手术时长均与术中浓缩红细胞输注风险增加(P<.001)和住院时间>5天风险增加(P<.001)相关。
- 开胸肺叶切除术的手术时长与肺炎(P<.001)、肺不张(P<.001)和非计划ICU入住(P=.006)风险增加相关。
- 手术时长与再入院(P=.549)或30天死亡率(P=.208)无关。
临床怎么用
- 外科医生和医院系统应采取不牺牲安全性和肿瘤学结局的措施来缩短手术时长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Longer bariatric, colorectal, plastic, spine, and urologic operations increase complications and lengths of stay. We aimed to determine whether this is a risk factor for lung lobectomy morbidity. METHODS: The Society of Thoracic Surgeons General Thoracic Surgery Database was queried for early-stage non-small cell lung cancer lobectomy with surgical duration treated as a continuous variable. Univariate and multivariate analyses compared patient and clinical characteristics with perioperative outcomes and procedure durations. Robotic cases were combined with thoracoscopic cases for duration analyses into a minimally invasive group. All analyses were conducted in SAS v9.4 (SAS Institute, Cary, NC) at a significance level of .05. RESULTS: In 17,852 patients mean duration of thoracotomy, thoracoscopy, and robotic lobectomies were 178 ± 84, 185 ± 73, and 214 ± 82 minutes, respectively (P < .001). The most common complications were prolonged air leak (12.3%), atrial fibrillation (12%), pneumonia (4.4%), and atelectasis requiring bronchoscopy (4.1%). Procedure duration was associated with increased odds of intraoperative packed red blood cell transfusion (P < .001) and length of stay > 5 days (P < .001) for both thoracotomy and minimally invasive lobectomy. Increased odds of pneumonia (P < .001), atelectasis (P < .001), and unexpected intensive care unit admission (P = .006) for thoracotomy lobectomy were associated with longer procedure duration. Increased lobectomy duration was not associated with readmission (P = .549) or 30-day mortality (P = .208). CONCLUSIONS: Longer early-stage lung cancer lobectomy durations are associated with postoperative morbidity and increased length of stay. Although the effects of protracted operation times on long-term survival are unknown, short-term mortality differences were not detected. Measures that decrease operative durations without sacrificing safety and oncologic outcome should be undertaken by surgeons and hospital systems.
引用
- Dexter E, Attwood K, Demmy T, et al. Does Operative Duration of Lobectomy for Early Lung Cancer Increase Perioperative Morbidity? Ann Thorac Surg. 2022. PMID: 35183506. doi:10.1016/j.athoracsur.2022.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。